<?xml version="1.0" encoding="UTF-8"?>
<bibdataset xsi:schemaLocation="http://www.elsevier.com/xml/ani/ani http://www.elsevier.com/xml/ani/ani512.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns="http://www.elsevier.com/xml/ani/ani">
<item>
<ait:process-info>
<ait:date-delivered year="2016" month="06" day="15"/>
<ait:date-sort year="2015" month="01" day="01"/>
<ait:status type="core" state="new" stage="S300"/>
</ait:process-info>
<bibrecord>
<item-info>
<copyright type="Elsevier">Copyright 2016 Elsevier B.V., All rights reserved.</copyright>
<itemidlist>
<ce:doi>10.3233/978-1-61499-564-7-975</ce:doi>
<itemid idtype="PUI">23174265</itemid>
<itemid idtype="CAR-ID">643592588</itemid>
<itemid idtype="NURSNG">2016002332</itemid>
<itemid idtype="SNEMB">2016001390</itemid>
</itemidlist>
<history>
<date-created timestamp="BST 05:16:11" year="2016" month="01" day="04"/>
</history>
<dbcollection>NURSNG</dbcollection>
<dbcollection>SNEMB</dbcollection>
</item-info>
<head>
<citation-info>
<citation-type code="cp"/>
<citation-language xml:lang="eng"/>
<abstract-language xml:lang="eng"/>
<author-keywords>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
<author-keyword>the</author-keyword>
</author-keywords>
</citation-info>
<citation-title>
<titletext xml:lang="eng" original="y">the</titletext>
</citation-title>
<author-group>
<author seq="1" type="auth">
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</author>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
</author-group>
<author-group>
<author seq="2" type="auth">
<ce:initials>Y.</ce:initials>
<ce:indexed-name>Nohara Y.</ce:indexed-name>
<ce:surname>Nohara</ce:surname>
<ce:given-name>Yasunobu</ce:given-name>
</author>
<author seq="6" type="auth">
<ce:initials>N.</ce:initials>
<ce:indexed-name>Nakashima N.</ce:indexed-name>
<ce:surname>Nakashima</ce:surname>
<ce:given-name>Naoki</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Medical Information Center</organization>
<organization>Kyushu University Hospital</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<author-group>
<author seq="3" type="auth">
<ce:initials>P.</ce:initials>
<ce:indexed-name>Ghosh P.</ce:indexed-name>
<ce:surname>Ghosh</ce:surname>
<ce:given-name>Partha</ce:given-name>
</author>
<author seq="4" type="auth">
<ce:initials>R.</ce:initials>
<ce:indexed-name>Islam Maruf R.</ce:indexed-name>
<ce:surname>Islam Maruf</ce:surname>
<ce:given-name>Rafiqul</ce:given-name>
</author>
<affiliation country="bgd">
<organization>Grameen Communications</organization>
<city>Dhaka</city>
</affiliation>
</author-group>
<author-group>
<author seq="5" type="auth">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Ahmed A.</ce:indexed-name>
<ce:surname>Ahmed</ce:surname>
<ce:given-name>Ashir</ce:given-name>
</author>
<affiliation country="jpn">
<organization>Graduate School of Information Science and Electrical Engineering</organization>
<organization>Kyushu University</organization>
<city>Fukuoka</city>
</affiliation>
</author-group>
<correspondence>
<person>
<ce:initials>M.</ce:initials>
<ce:indexed-name>Nishikitani M.</ce:indexed-name>
<ce:surname>Nishikitani</ce:surname>
<ce:given-name>Mariko</ce:given-name>
</person>
<affiliation country="jpn">
<organization>Institute of Decision Science for A Sustainable Society</organization>
<organization>Kyushu University</organization>
<address-part>3-1-1 Maidashi</address-part>
<city>Fukuoka</city>
<postal-code>812-8582</postal-code>
</affiliation>
<ce:e-address>makorin@med.kyushu-u.ac.jp</ce:e-address>
</correspondence>
<abstracts>
<abstract original="y">
<publishercopyright>© 2015 IMIA and IOS Press.</publishercopyright>
<ce:para>Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors. We have recently reported that selective cannabinoid 2 (CB(2)) receptor agonists upregulate 5-HT(2A) receptors by enhancing ERK1/2 signaling in prefrontal cortex (PFCx). Increased activity of cortical 5-HT(2A) receptors has been associated with several neuropsychiatric disorders such as anxiety and schizophrenia. Here we examine the mechanisms involved in this enhanced ERK1/2 activation in rat PFCx and in a neuronal cell model. Sprague-Dawley rats treated with a non-selective cannabinoid agonist (CP55940, 50μg/kg, 7 days, i.p.) showed enhanced co-immunoprecipitation of β-Arrestin 2 and ERK1/2, enhanced pERK protein levels, and enhanced expression of β-Arrestin 2 mRNA and protein levels in PFCx. In a neuronal cell line, we found that selective CB(2) receptor agonists upregulate β-Arrestin 2, an effect that was prevented by selective CB(2) receptor antagonist JTE-907 and CB(2) shRNA lentiviral particles. Additionally, inhibition of clathrin-mediated endocytosis, ERK1/2, and the AP-1 transcription factor also prevented the cannabinoid receptor-induced upregulation of β-Arrestin 2. Our results suggest that sustained activation of CB(2) receptors would enhance β-Arrestin 2 expression possibly contributing to its increased interaction with ERK1/2, thereby driving the upregulation of 5-HT(2A) receptors. The CB(2) receptor-mediated upregulation of β-Arrestin 2 would be mediated, at least in part, by an ERK1/2-dependent activation of AP-1. These data could provide the rationale for some of the adverse effects associated with repeated cannabinoid exposure and shed light on some CB(2) receptor agonists that could represent an alternative therapeutic because of their minimal effect on serotonergic neurotransmission.</ce:para>
</abstract>
</abstracts>
<source type="k" country="nld">
<sourcetitle>Studies in Health Technology and Informatics</sourcetitle>
<sourcetitle-abbrev>Stud. Health Technol. Informatics</sourcetitle-abbrev>
<translated-sourcetitle xml:lang="eng">Studies in Health Technology and Informatics</translated-sourcetitle>
<issuetitle>MEDINFO 2015: eHealth-Enabled Health - Proceedings of the 15th World Congress on Health and Biomedical Informatics</issuetitle>
<issn type="electronic">18798365</issn>
<issn type="print">09269630</issn>
<isbn type="electronic" length="13" level="volume">9781614995630</isbn>
<volisspag>
<voliss volume="216"/>
<pagerange first="975"/>
</volisspag>
<publicationyear first="2015"/>
<publicationdate>
<year>2015</year>
</publicationdate>
<website>
<ce:e-address>http://www.iospress.nl/bookserie/studies-in-health-technology-and-informatics/</ce:e-address>
</website>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>A.</ce:initials>
<ce:indexed-name>Georgiou A.</ce:indexed-name>
<ce:surname>Georgiou</ce:surname>
<ce:given-name>Andrew</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>I.N.</ce:initials>
<ce:indexed-name>Sarkar I.N.</ce:indexed-name>
<ce:degrees>Dr.</ce:degrees>
<ce:surname>Sarkar</ce:surname>
<ce:given-name>Indra Neil</ce:given-name>
</contributor>
</contributor-group>
<contributor-group>
<contributor seq="1" role="edit">
<ce:initials>P.M.</ce:initials>
<ce:indexed-name>de Azevedo Marques P.M.</ce:indexed-name>
<ce:surname>de Azevedo Marques</ce:surname>
<ce:given-name>Paulo Mazzoncini</ce:given-name>
</contributor>
</contributor-group>
<publisher>
<publishername>IOS Press</publishername>
<affiliation country="nld">
<address-part>Nieuwe Hemweg 6B</address-part>
<city>Amsterdam</city>
<postal-code>1013 BG</postal-code>
</affiliation>
</publisher>
<additional-srcinfo>
<conferenceinfo>
<confevent>
<confname>15th World Congress on Health and Biomedical Informatics, MEDINFO 2015</confname>
<confnumber>15</confnumber>
<conftheme>eHealth-Enabled Health</conftheme>
<confseriestitle>World Congress on Health and Biomedical Informatics</confseriestitle>
<conflocation country="bra">
<city>Sao Paulo</city>
</conflocation>
<confdate>
<startdate year="2015" month="08" day="19"/>
<enddate year="2015" month="08" day="23"/>
</confdate>
<confcode>116956</confcode>
<confsponsors complete="n">
<confsponsor></confsponsor>
</confsponsors>
</confevent>
</conferenceinfo>
</additional-srcinfo>
</source>
<enhancement>
<classificationgroup>
<classifications type="ASJC">
<classification>2204</classification>
<classification>2718</classification>
<classification>3605</classification>
</classifications>
</classificationgroup>
</enhancement>
</head>
<tail>
<bibliography refcount="1"/>
</tail>
</bibrecord>
</item>
</bibdataset>
